BIIB
USDBiogen Inc. Common Stock
Real-time Price
Price Chart
Key Metrics
Market Metrics
Open
$155.700
High
$156.220
Low
$154.010
Volume
1.72M
Company Fundamentals
Market Cap
22.7B
Industry
Drug Manufacturers - General
Country
United States
Trading Stats
Avg Volume
1.64M
Exchange
NMS
Currency
USD
52-Week Range
Related News
Bernstein Maintains Market Perform on Biogen, Raises Price Target to $157
Bernstein analyst William Pickering maintains Biogen with a Market Perform and raises the price target from $155 to $157.
Biogen to Highlight Scientific Progress in Rare Kidney Disease at American Society of Nephrology (ASN) Kidney Week 2025
Oral presentation to share first-of-its-kind longitudinal gene expression data in IgA nephropathy, unveiling novel insights into the mechanism of action of felzartamab and advancing the understanding of its disease
RBC Capital Maintains Outperform on Biogen, Lowers Price Target to $210
RBC Capital analyst Brian Abrahams maintains Biogen with a Outperform and lowers the price target from $217 to $210.
Biogen tops quarterly profit estimates, eyes deals to build early-stage pipeline
Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple sclerosis treatments.
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.